Literature DB >> 22411716

Reduction in postoperative high-density lipoprotein cholesterol levels in children undergoing the Fontan operation.

Sinai C Zyblewski1, W Scott Argraves, Eric M Graham, Elizabeth H Slate, Andrew M Atz, Scott M Bradley, Tim C McQuinn, Brent A Wilkerson, Shane B Wing, Kelley M Argraves.   

Abstract

Despite the emerging relevance of high-density lipoprotein (HDL) in the inflammatory cascade and vascular barrier integrity, HDL levels in children undergoing cardiac surgery are unexplored. As a measure of HDL levels, the HDL-cholesterol (HDL-C) in single-ventricle patients was quantified before and after the Fontan operation, and it was determined whether relationships existed between the duration and the type of postoperative pleural effusions. The study prospectively enrolled 12 children undergoing the Fontan operation. Plasma HDL-C levels were measured before and after cardiopulmonary bypass. The outcome variables of interest were the duration and type of chest tube drainage (chylous vs. nonchylous). The Kendall rank correlation coefficient and the Wilcoxon rank sum test were used. There were 11 complete observations. The median preoperative HDL-C level for all the subjects was 30 mg/dl (range, 24-53 mg/dl), and the median postcardiopulmonary bypass level was 21 mg/dl (range, 14-46 mg/dl) (p = 0.004). There was a tendency toward a moderate inverse correlation (-0.42) between the postcardiopulmonary bypass HDL-C level and the duration of chest tube drainage, but the result was not statistically significant (p = 0.07). In the chylous effusion group, the median postcardiopulmonary bypass HDL-C tended to be lower (16 vs. 23 mg/dl; p = 0.09). After the Fontan operation, the plasma HDL-C levels in children are significantly reduced. It is reasonable to conclude that the reduction in HDL-C reflects reduced plasma levels of HDL particles, which may have pertinent implications in postoperative pleural effusions given the antiinflammatory and endothelial barrier functions of HDL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22411716      PMCID: PMC4356128          DOI: 10.1007/s00246-012-0274-z

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  22 in total

1.  Cyanotic congenital heart disease and coronary artery atherogenesis.

Authors:  Alistair Fyfe; Joseph K Perloff; Koichiro Niwa; John S Child; Pamela D Miner
Journal:  Am J Cardiol       Date:  2005-07-15       Impact factor: 2.778

2.  Surgical repair of tricuspid atresia.

Authors:  F Fontan; E Baudet
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

3.  Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation.

Authors:  Stefan Barlage; Carsten Gnewuch; Gerhard Liebisch; Zsuzsanna Wolf; Franz-Xaver Audebert; Thomas Glück; Dieter Fröhlich; Bernhard K Krämer; Gregor Rothe; Gerd Schmitz
Journal:  Intensive Care Med       Date:  2009-08-08       Impact factor: 17.440

4.  Impact of the off-pump Fontan procedure on complement activation and cytokine generation.

Authors:  Yoichi Kawahira; Hideki Uemura; Toshikatsu Yagihara
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

Review 5.  The versatility of HDL: a crucial anti-inflammatory regulator.

Authors:  Marcus D Säemann; Marko Poglitsch; Chantal Kopecky; Michael Haidinger; Walter H Hörl; Thomas Weichhart
Journal:  Eur J Clin Invest       Date:  2010-12       Impact factor: 4.686

6.  Fontan operation in the current era: a 15-year single institution experience.

Authors:  Jennifer C Hirsch; Caren Goldberg; Edward L Bove; Sepand Salehian; Timothy Lee; Richard G Ohye; Eric J Devaney
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

7.  Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study.

Authors:  Page A W Anderson; Lynn A Sleeper; Lynn Mahony; Steven D Colan; Andrew M Atz; Roger E Breitbart; Welton M Gersony; Dianne Gallagher; Tal Geva; Renee Margossian; Brian W McCrindle; Stephen Paridon; Marcy Schwartz; Mario Stylianou; Richard V Williams; Bernard J Clark
Journal:  J Am Coll Cardiol       Date:  2008-07-08       Impact factor: 24.094

8.  Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells.

Authors:  Mohammad Tauseef; Vidisha Kini; Nebojsa Knezevic; Melissa Brannan; Ram Ramchandaran; Henrik Fyrst; Julie Saba; Stephen M Vogel; Asrar B Malik; Dolly Mehta
Journal:  Circ Res       Date:  2008-10-10       Impact factor: 17.367

9.  High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function.

Authors:  Kelley M Argraves; Patrick J Gazzolo; Eric M Groh; Brent A Wilkerson; Bryan S Matsuura; Waleed O Twal; Samar M Hammad; W Scott Argraves
Journal:  J Biol Chem       Date:  2008-07-07       Impact factor: 5.157

10.  Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey.

Authors:  T B Hickman; R R Briefel; M D Carroll; B M Rifkind; J I Cleeman; K R Maurer; C L Johnson
Journal:  Prev Med       Date:  1998 Nov-Dec       Impact factor: 4.018

View more
  6 in total

1.  The use of correlation functions in thoracic surgery research.

Authors:  Lucile Gust; Xavier Benoit D'journo
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

2.  Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1.

Authors:  Brent A Wilkerson; G Daniel Grass; Shane B Wing; W Scott Argraves; Kelley M Argraves
Journal:  J Biol Chem       Date:  2012-11-07       Impact factor: 5.157

3.  Targeted metabolomic analysis of serum phospholipid and acylcarnitine in the adult Fontan patient with a dominant left ventricle.

Authors:  Miriam Michel; Karl-Otto Dubowy; Manuela Zlamy; Daniela Karall; Mark Gordian Adam; Andreas Entenmann; Markus Andreas Keller; Jakob Koch; Irena Odri Komazec; Ralf Geiger; Christina Salvador; Christian Niederwanger; Udo Müller; Sabine Scholl-Bürgi; Kai Thorsten Laser
Journal:  Ther Adv Chronic Dis       Date:  2020-04-27       Impact factor: 5.091

4.  Method comparison of HPLC-ninhydrin-photometry and UHPLC-PITC-tandem mass spectrometry for serum amino acid analyses in patients with complex congenital heart disease and controls.

Authors:  Miriam Michel; Christina Salvador; Verena Wiedemair; Mark Gordian Adam; Kai Thorsten Laser; Karl-Otto Dubowy; Andreas Entenmann; Daniela Karall; Ralf Geiger; Manuela Zlamy; Sabine Scholl-Bürgi
Journal:  Metabolomics       Date:  2020-12-15       Impact factor: 4.290

5.  Long-Term Abnormalities of Lipid Profile After a Single Episode of Sepsis.

Authors:  Nicholas Felici; Da Liu; Josh Maret; Mariana Restrepo; Yuliya Borovskiy; Jihane Hajj; Wesley Chung; Krzysztof Laudanski
Journal:  Front Cardiovasc Med       Date:  2021-11-15

6.  Targeted metabolomic analysis of serum amino acids in the adult Fontan patient with a dominant left ventricle.

Authors:  Miriam Michel; Karl-Otto Dubowy; Andreas Entenmann; Daniela Karall; Mark Gordian Adam; Manuela Zlamy; Irena Odri Komazec; Ralf Geiger; Christian Niederwanger; Christina Salvador; Udo Müller; Kai Thorsten Laser; Sabine Scholl-Bürgi
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.